Tapewire

NYSE · USD

QSR

Restaurant Brands International Inc.

Export transactions ↓
Tapewire entity
3102
SEC CIK
0001618756
Parsed reports
905

Last 12 months

Inside the activity.

0 purchase rows · 63 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 2025029
Jan 2026010
Feb 202609
Mar 202608
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
SANTELMO THIAGO TPresident, International
GrantRestricted Share Units · Derivative 16.5534 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000221 · wk-form4_1744149069.xml · derivative · entry 7

SANTELMO THIAGO T · CIK 0002015936 · President, International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,827.2792

Underlying: Common Shares · 16.5534 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
CURTIS THOMAS BENJAMINPres., BK US & CA
GrantPerformance Share Units · Derivative 560.9345 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 8

CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,919.9345

Underlying: Common Shares · 560.9345 shares

Expires 2028-03-15

F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
CURTIS THOMAS BENJAMINPres., BK US & CA
GrantRestricted Share Units · Derivative 85.7871 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 7

CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,469.7871

Underlying: Common Shares · 85.7871 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
CURTIS THOMAS BENJAMINPres., BK US & CA
GrantPerformance Share Units · Derivative 563.9081 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 6

CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,248.1779

Underlying: Common Shares · 563.9081 shares

Expires 2027-03-15

F8 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
CURTIS THOMAS BENJAMINPres., BK US & CA
GrantRestricted Share Units · Derivative 102.8877 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 5

CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,357.4745

Underlying: Common Shares · 102.8877 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F7 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

F7 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
CURTIS THOMAS BENJAMINPres., BK US & CA
GrantPerformance Share Units · Derivative 431.5172 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 4

CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,633.931

Underlying: Common Shares · 431.5172 shares

Expires 2026-02-22

F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
CURTIS THOMAS BENJAMINPres., BK US & CA
GrantRestricted Share Units · Derivative 44.2724 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 3

CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,887.1036

Underlying: Common Shares · 44.2724 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026.

F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
CURTIS THOMAS BENJAMINPres., BK US & CA
GrantRestricted Share Units · Derivative 23.1302 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000219 · wk-form4_1744149049.xml · derivative · entry 2

CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,553.2765

Underlying: Common Shares · 23.1302 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F3 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

F3 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
DOYLE J PATRICKDirector · Executive Chairman
GrantPerformance Share Units · Derivative 7,370.0864 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000222 · wk-form4_1744149080.xml · derivative · entry 5

DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 813,562.4449

Underlying: Common Shares · 7,370.0864 shares

Expires not disclosed

F5 · derivative.exercise_price: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares.

F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F5 · derivative.exercise_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares.

F5 · derivative.expiration_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
DOYLE J PATRICKDirector · Executive Chairman
GrantRestricted Share Units · Derivative 2,948.0346 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000222 · wk-form4_1744149080.xml · derivative · entry 4

DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,424.978

Underlying: Common Shares · 2,948.0346 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F4 · derivative.exercise_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027.

F4 · derivative.expiration_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Granat JillSee Remarks
GrantPerformance Share Units · Derivative 385.6396 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 11

Granat Jill · CIK 0001552022 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,569.6396

Underlying: Common Shares · 385.6396 shares

Expires 2028-03-15

F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Granat JillSee Remarks
GrantRestricted Share Units · Derivative 89.5535 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 10

Granat Jill · CIK 0001552022 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,885.5535

Underlying: Common Shares · 89.5535 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Granat JillSee Remarks
GrantPerformance Share Units · Derivative 313.2823 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 9

Granat Jill · CIK 0001552022 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,582.3211

Underlying: Common Shares · 313.2823 shares

Expires 2027-03-15

F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Granat JillSee Remarks
GrantRestricted Share Units · Derivative 103.5867 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 8

Granat Jill · CIK 0001552022 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,434.6369

Underlying: Common Shares · 103.5867 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Granat JillSee Remarks
GrantPerformance Share Units · Derivative 323.6379 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 7

Granat Jill · CIK 0001552022 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,725.4483

Underlying: Common Shares · 323.6379 shares

Expires 2026-02-22

F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Granat JillSee Remarks
GrantRestricted Share Units · Derivative 69.9218 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 6

Granat Jill · CIK 0001552022 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,718.4611

Underlying: Common Shares · 69.9218 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F6 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026.

F6 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Granat JillSee Remarks
GrantRestricted Share Units · Derivative 43.2351 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000218 · wk-form4_1744149038.xml · derivative · entry 5

Granat Jill · CIK 0001552022 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,772.5942

Underlying: Common Shares · 43.2351 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC GrantPerformance Share Units · Derivative 154.2504 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 11

Friesner Jacqueline · CIK 0001552051 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,027.2504

Underlying: Common Shares · 154.2504 shares

Expires 2028-03-15

F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase and decrease based on the results of the performance period.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC GrantRestricted Share Units · Derivative 40.343 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 10

Friesner Jacqueline · CIK 0001552051 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,453.343

Underlying: Common Shares · 40.343 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC GrantPerformance Share Units · Derivative 154.6149 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 9

Friesner Jacqueline · CIK 0001552051 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,067.4937

Underlying: Common Shares · 154.6149 shares

Expires 2027-03-15

F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC GrantRestricted Share Units · Derivative 46.7869 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 8

Friesner Jacqueline · CIK 0001552051 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,164.6687

Underlying: Common Shares · 46.7869 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC GrantPerformance Share Units · Derivative 129.4552 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 7

Friesner Jacqueline · CIK 0001552051 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,290.1794

Underlying: Common Shares · 129.4552 shares

Expires 2026-02-22

F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC GrantRestricted Share Units · Derivative 33.9912 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 6

Friesner Jacqueline · CIK 0001552051 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,752.194

Underlying: Common Shares · 33.9912 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026.

F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC GrantRestricted Share Units · Derivative 18.3038 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000215 · wk-form4_1744149007.xml · derivative · entry 5

Friesner Jacqueline · CIK 0001552051 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,020.5062

Underlying: Common Shares · 18.3038 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Kobza JoshuaChief Executive Officer
GrantPerformance Share Units · Derivative 1,402.3318 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 10

Kobza Joshua · CIK 0001574771 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,799.3318

Underlying: Common Shares · 1,402.3318 shares

Expires 2028-03-15

F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Kobza JoshuaChief Executive Officer
GrantRestricted Share Units · Derivative 178.5128 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 9

Kobza Joshua · CIK 0001574771 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,705.5128

Underlying: Common Shares · 178.5128 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Kobza JoshuaChief Executive Officer
GrantPerformance Share Units · Derivative 1,127.8256 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 8

Kobza Joshua · CIK 0001574771 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,497.3985

Underlying: Common Shares · 1,127.8256 shares

Expires 2027-03-15

F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Kobza JoshuaChief Executive Officer
GrantRestricted Share Units · Derivative 217.2242 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 7

Kobza Joshua · CIK 0001574771 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,978.7444

Underlying: Common Shares · 217.2242 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Kobza JoshuaChief Executive Officer
GrantPerformance Share Units · Derivative 2,923.5583 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 6

Kobza Joshua · CIK 0001574771 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 322,723.1101

Underlying: Common Shares · 2,923.5583 shares

Expires 2028-05-21

F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning February 22, 2023 and ending May 21, 2028 and to the extent earned will vest on May 28, 2028, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Kobza JoshuaChief Executive Officer
GrantRestricted Share Units · Derivative 126.2782 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 5

Kobza Joshua · CIK 0001574771 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,939.4868

Underlying: Common Shares · 126.2782 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026.

F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Kobza JoshuaChief Executive Officer
GrantRestricted Share Units · Derivative 77.4144 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000224 · wk-form4_1744149102.xml · derivative · entry 4

Kobza Joshua · CIK 0001574771 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,545.5461

Underlying: Common Shares · 77.4144 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Schwan AxelPres., Tim Hortons Americas
GrantPerformance Share Units · Derivative 560.9345 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 11

SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,919.9345

Underlying: Common Shares · 560.9345 shares

Expires 2028-03-15

F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Schwan AxelPres., Tim Hortons Americas
GrantRestricted Share Units · Derivative 110.4518 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 10

SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,192.4518

Underlying: Common Shares · 110.4518 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F10 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F10 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Schwan AxelPres., Tim Hortons Americas
GrantPerformance Share Units · Derivative 501.2516 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 9

SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,331.7137

Underlying: Common Shares · 501.2516 shares

Expires 2027-03-15

F9 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Schwan AxelPres., Tim Hortons Americas
GrantRestricted Share Units · Derivative 94.6601 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 8

SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,449.2519

Underlying: Common Shares · 94.6601 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F8 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

F8 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Schwan AxelPres., Tim Hortons Americas
GrantPerformance Share Units · Derivative 719.1953 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 7

SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,389.885

Underlying: Common Shares · 719.1953 shares

Expires 2026-02-22

F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Schwan AxelPres., Tim Hortons Americas
GrantRestricted Share Units · Derivative 76.4316 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 6

SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,437.0579

Underlying: Common Shares · 76.4316 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026.

F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:50 UTC
Schwan AxelPres., Tim Hortons Americas
GrantRestricted Share Units · Derivative 35.1911 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000216 · wk-form4_1744149017.xml · derivative · entry 5

SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,884.6437

Underlying: Common Shares · 35.1911 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Fulton DuncanChief Corporate Officer
GrantPerformance Share Units · Derivative 214.9229 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 10

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,222.9229

Underlying: Common Shares · 214.9229 shares

Expires 2028-03-15

F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Fulton DuncanChief Corporate Officer
GrantRestricted Share Units · Derivative 58.5601 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 9

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,327.5601

Underlying: Common Shares · 58.5601 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F12 · derivative.exercise_date: These restricted share units vest in equal annual installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F12 · derivative.expiration_date: These restricted share units vest in equal annual installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Fulton DuncanChief Corporate Officer
GrantPerformance Share Units · Derivative 191.4321 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 8

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,684.6912

Underlying: Common Shares · 191.4321 shares

Expires 2027-03-15

F11 · derivative.exercise_price: The shares reported represent an award of perforamnce based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning Febuary 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be eaned at the end of hte performance period is subject to increase or decrease based on the results of the performance condition.

F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Fulton DuncanChief Corporate Officer
GrantRestricted Share Units · Derivative 69.5538 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 7

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,515.4483

Underlying: Common Shares · 69.5538 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F10 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

F10 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Fulton DuncanChief Corporate Officer
GrantPerformance Share Units · Derivative 216.7651 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 6

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,421.9707

Underlying: Common Shares · 216.7651 shares

Expires 2026-02-22

F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Fulton DuncanChief Corporate Officer
GrantRestricted Share Units · Derivative 44.2512 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 5

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,781.4432

Underlying: Common Shares · 44.2512 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F7 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026.

F7 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Fulton DuncanChief Corporate Officer
GrantRestricted Share Units · Derivative 29.0306 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000223 · wk-form4_1744149092.xml · derivative · entry 4

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,136.8243

Underlying: Common Shares · 29.0306 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Siddiqui Sami A.Chief Financial Officer
GrantPerformance Share Units · Derivative 631.0434 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 11

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,659.0434

Underlying: Common Shares · 631.0434 shares

Expires 2028-03-15

F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Siddiqui Sami A.Chief Financial Officer
GrantRestricted Share Units · Derivative 91.7841 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 10

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,131.7841

Underlying: Common Shares · 91.7841 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Siddiqui Sami A.Chief Financial Officer
GrantPerformance Share Units · Derivative 438.5952 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 9

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,415.2495

Underlying: Common Shares · 438.5952 shares

Expires 2027-03-15

F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Siddiqui Sami A.Chief Financial Officer
GrantRestricted Share Units · Derivative 98.7597 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 8

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,901.7991

Underlying: Common Shares · 98.7597 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Siddiqui Sami A.Chief Financial Officer
GrantPerformance Share Units · Derivative 359.5977 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 7

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,694.9426

Underlying: Common Shares · 359.5977 shares

Expires 2026-02-22

F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.